Items Tagged ‘wild-type’

August 11th, 2015

Vectibix® Improves Survival in Patients with Wild-Type KRAS Metastatic Colorectal Cancer after Progression on Chemotherapy

By

  Vectibix® (panitumumab) appears to improve overall survival among patients with wild-type KRAS metastatic colorectal cancer that has progressed on or following chemotherapy. A Phase III trial of Vectibix is currently underway, but researchers have announced that that drug has extended overall survival, the primary goal of the study. Vectibix is a targeted therapy that […]

View full entry

Tags: Colon Cancer, colorectal cancer, kras, metastatic colorectal cancer, News, panitumumab, Rectal Cancer, Recurrent/Relapsed Rectal Cancer, Stage IV (D)/Relapsed Colon Cancer, Stage IV Rectal Cancer, vectibix, wild-type